We are looking to match your Covid-19-related innovations with the right investors – receive a free company valuation report

We are not manufacturers of face masks or gloves. Nor do we know how to develop the next-generation vaccine. But YOU do. As time is of the essence now, we want to contribute by offering our expertise in connecting companies with investors to fast-track their innovations.

In case you are in the process of developing COVID-19-related innovations of any type and you are in need of private investment or funding, please drop us an email:

• Lukas Rieder (lukas.rieder@m27.eu)
• Manuel Ferreyra (manuel.ferreyra@m27.eu)

You will receive a free company valuation report according to six valuation methods (Berkus, Scorecard, Risk Factor Summation, SVC, DCF, Multiples) as well as our proprietary Company Success Readiness Level. Following the scoring, we will reach out to our network of investors, who have confirmed having funding available for COVID-19-related innovations. And hopefully, there will be a match.

In the meantime, take care and stay safe!